Xponance, Inc. Amicus Therapeutics, Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 18,967 shares of FOLD stock, worth $187,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,967

Previous 18,555 2.22%

Holding current value

$187,583

Previous $184,000 9.78%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$9.55 - $12.09 $3,934 - $4,981	412 Added 2.22%	18,967 $202,000
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $8,461 - $10,998	936 Added 5.31%	18,555 $184,000
Q1 2024 May 13, 2024	BUY	$11.43 - $14.24 $4,960 - $6,180	434 Added 2.53%	17,619 $207,000
Q4 2023 Jan 31, 2024	BUY	$9.97 - $14.52 $6,759 - $9,844	678 Added 4.11%	17,185 $243,000
Q3 2023 Oct 23, 2023	BUY	$11.78 - $13.86 $718 - $845	61 Added 0.37%	16,507 $200,000
Q2 2023 Jul 13, 2023	BUY	$10.72 - $13.3 $4,941 - $6,131	461 Added 2.88%	16,446 $206,000
Q1 2023 Apr 17, 2023	BUY	$10.91 - $13.54 $2,334 - $2,897	214 Added 1.36%	15,985 $177,000
Q4 2022 Jan 23, 2023	BUY	$9.89 - $12.7 $2,601 - $3,340	263 Added 1.7%	15,771 $0
Q3 2022 Oct 24, 2022	BUY	$9.82 - $12.75 $5,941 - $7,713	605 Added 4.06%	15,508 $162,000
Q2 2022 Aug 02, 2022	BUY	$6.23 - $11.12 $14,927 - $26,643	2,396 Added 19.16%	14,903 $160,000
Q1 2022 Apr 20, 2022	SELL	$7.89 - $12.48 $465 - $736	-59 Reduced 0.47%	12,507 $118,000
Q4 2021 Jan 31, 2022	BUY	$9.82 - $12.44 $1,905 - $2,413	194 Added 1.57%	12,566 $145,000
Q3 2021 Nov 05, 2021	SELL	$8.74 - $11.84 $15,723 - $21,300	-1,799 Reduced 12.69%	12,372 $118,000
Q2 2021 Aug 12, 2021	BUY	$8.71 - $10.72 $123,429 - $151,913	14,171 New	14,171 $137,000
Q3 2020 Oct 26, 2020	SELL	$12.89 - $15.89 $152,952 - $188,550	-11,866 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $105,132 - $186,177	11,866 New	11,866 $179,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.77B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account